| Vaccine efficacy of ALVAC-HIV and bivalent subtype c gp120–MF59 in adults GE Gray, LG Bekker, F Laher, M Malahleha, M Allen, Z Moodie, ... New England Journal of Medicine 384 (12), 1089-1100, 2021 | 194 | 2021 |
| Pharmacokinetics of isoniazid, pyrazinamide, and ethambutol in newly diagnosed pulmonary TB patients in Tanzania P Denti, K Jeremiah, E Chigutsa, D Faurholt-Jepsen, G PrayGod, ... PloS one 10 (10), e0141002, 2015 | 110 | 2015 |
| PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized … C Celum, S Hosek, M Tsholwana, S Kassim, S Mukaka, BJ Dye, S Pathak, ... PLoS medicine 18 (6), e1003670, 2021 | 102 | 2021 |
| Pharmacokinetics of efavirenz and treatment of HIV-1 among pregnant women with and without tuberculosis coinfection KE Dooley, P Denti, N Martinson, S Cohn, F Mashabela, J Hoffmann, ... The Journal of infectious diseases 211 (2), 197-205, 2015 | 97 | 2015 |
| Progress towards the UNAIDS 90–90-90 goals by age and gender in a rural area of KwaZulu-Natal, South Africa: a household-based community cross-sectional survey H Huerga, G Van Cutsem, J Ben Farhat, A Puren, M Bouhenia, L Wiesner, ... BMC public health 18, 1-8, 2018 | 93 | 2018 |
| Pharmacokinetics of rifampin, isoniazid, pyrazinamide, and ethambutol in infants dosed according to revised WHO-recommended treatment guidelines A Bekker, HS Schaaf, HR Draper, L van der Laan, S Murray, L Wiesner, ... Antimicrobial agents and chemotherapy 60 (4), 2171-2179, 2016 | 90 | 2016 |
| Pharmacokinetics and safety of moxifloxacin in children with multidrug-resistant tuberculosis S Thee, AJ Garcia-Prats, HR Draper, HM McIlleron, L Wiesner, S Castel, ... Clinical Infectious Diseases 60 (4), 549-556, 2015 | 86 | 2015 |
| Drug–drug interactions between bedaquiline and the antiretrovirals lopinavir/ritonavir and nevirapine in HIV-infected patients with drug-resistant TB M Pandie, L Wiesner, H McIlleron, J Hughes, S Siwendu, F Conradie, ... Journal of Antimicrobial Chemotherapy 71 (4), 1037-1040, 2016 | 74 | 2016 |
| Interaction between artemether-lumefantrine and nevirapine-based antiretroviral therapy in HIV-1-infected patients T Kredo, K Mauff, JS Van der Walt, L Wiesner, G Maartens, K Cohen, ... Antimicrobial agents and chemotherapy 55 (12), 5616-5623, 2011 | 73 | 2011 |
| Nutritional supplementation increases rifampin exposure among tuberculosis patients coinfected with HIV K Jeremiah, P Denti, E Chigutsa, D Faurholt-Jepsen, G PrayGod, ... Antimicrobial agents and chemotherapy 58 (6), 3468-3474, 2014 | 67 | 2014 |
| UCT943, a next-generation Plasmodium falciparum PI4K inhibitor preclinical candidate for the treatment of malaria C Brunschwig, N Lawrence, D Taylor, E Abay, M Njoroge, GS Basarab, ... Antimicrobial agents and chemotherapy 62 (9), 10.1128/aac. 00012-18, 2018 | 66 | 2018 |
| Efficacy and safety of artemether–lumefantrine, artesunate–amodiaquine, and dihydroartemisinin–piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in … E Davlantes, PR Dimbu, CM Ferreira, M Florinda Joao, D Pode, J Félix, ... Malaria journal 17, 1-11, 2018 | 65 | 2018 |
| Improved antiparasitic activity by incorporation of organosilane entities into half-sandwich ruthenium (II) and rhodium (III) thiosemicarbazone complexes M Adams, C de Kock, PJ Smith, KM Land, N Liu, M Hopper, A Hsiao, ... Dalton Transactions 44 (5), 2456-2468, 2015 | 64 | 2015 |
| Pharmacokinetics of ofloxacin and levofloxacin for prevention and treatment of multidrug-resistant tuberculosis in children S Thee, AJ Garcia-Prats, HM McIlleron, L Wiesner, S Castel, J Norman, ... Antimicrobial agents and chemotherapy 58 (5), 2948-2951, 2014 | 64 | 2014 |
| Undisclosed HIV infection and antiretroviral therapy use in the Kenya AIDS indicator survey 2012: relevance to national targets for HIV diagnosis and treatment AA Kim, I Mukui, PW Young, J Mirjahangir, S Mwanyumba, J Wamicwe, ... Aids 30 (17), 2685-2695, 2016 | 59 | 2016 |
| Pharmacokinetics and safety of rifabutin in young HIV-infected children receiving rifabutin and lopinavir/ritonavir H Moultrie, H McIlleron, S Sawry, T Kellermann, L Wiesner, G Kindra, ... Journal of Antimicrobial Chemotherapy 70 (2), 543-549, 2015 | 58 | 2015 |
| Synthesis and evaluation of hybrid drugs for a potential HIV/AIDS-malaria combination therapy MN Aminake, A Mahajan, V Kumar, R Hans, L Wiesner, D Taylor, ... Bioorganic & medicinal chemistry 20 (17), 5277-5289, 2012 | 58 | 2012 |
| Moxifloxacin population pharmacokinetics and model-based comparison of efficacy between moxifloxacin and ofloxacin in African patients SP Zvada, P Denti, FA Sirgel, E Chigutsa, M Hatherill, S Charalambous, ... Antimicrobial agents and chemotherapy 58 (1), 503-510, 2014 | 57 | 2014 |
| Viral suppression following switch to second-line antiretroviral therapy: associations with nucleoside reverse transcriptase inhibitor resistance and subtherapeutic drug … V Johnston, K Cohen, L Wiesner, L Morris, J Ledwaba, KL Fielding, ... The Journal of infectious diseases 209 (5), 711-720, 2014 | 55 | 2014 |
| Exploring the pharmacokinetics of oral ketamine in children undergoing burns procedures KEJ Brunette, BJ Anderson, J Thomas, L Wiesner, DW Herd, S Schulein Pediatric Anesthesia 21 (6), 653-662, 2011 | 54 | 2011 |
